Sage Journals: Discover world-class research

Free access

Research article

First published 2012-1

Comparative Long-Term Preclinical Safety Evaluation of Two Glatiramoid Compounds (Glatiramer Acetate,Copaxone®,and TV-5010,Protiramer) in Rats and Monkeys

Yuval Ramot, Moti Rosenstock, Ety Klinger [...]

Toxicologic Pathology

Retricted access

Research article

First published 2001-12

A prospective,open-label treatment trial to compare the effect of IFNβ-1a (Avonex®),IFNβ-1b (Betaseron®),and glatiramer acetate (Copaxone®) on the relapse rate in relapsing-remitting multiple sclerosis: results after 18 months of therapy

Omar A Khan, Alexandros C Tselis, John A Kamholz [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2008-07

Reduction of free radicals in multiple sclerosis: effect of glatiramer acetate (Copaxone®)

C Iarlori, D Gambi, A Lugaresi [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2002-12

Effect of combined IFNb-1a and glatiramer acetate therapy on GA-specific T-cell responses in multiple sclerosis

S Dhib-Jalbut, M Chen, K Henschel [...]

Multiple Sclerosis Journal

Free access

Review article

First published 2011-9

Efficacy,safety,and cost-effectiveness of glatiramer acetate in the treatment of relapsing–remitting multiple sclerosis

Aaron Boster, Mary Pat Bartoszek, Colleen O’Connell [...]

Therapeutic Advances in Neurological Disorders

Retricted access

Research article

First published 2001-08

Glatiramer acetate induces a Th2-biased response and crossreactivity with myelin basic protein in patients with MS

M Chen, B Gran, K Costello [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2006-06

A prospective open-label study of glatiramer acetate: over a decade of continuous use in multiple sclerosis patients

C C Ford, K P Johnson, R P Lisak [...]

Multiple Sclerosis Journal

Open access

Review article

First published 2011

Glatiramer Acetate in the Reduction of Relapse Frequency in Multiple Sclerosis

Augusto Miravalle, Barry Hendin, Timothy L. Vollmer [...]

Clinical Medicine Insights: Therapeutics

Retricted access

Review article

First published 2010-10

PEGylated Interferon Beta-1a: Meeting an Unmet Medical Need in the Treatment of Relapsing Multiple Sclerosis

Darren P. Baker, Robert Blake Pepinsky, Margot Brickelmaier [...]

Journal of Interferon & Cytokine Research

Retricted access

Research article

First published 2011-11

Contact dermatitis induced by glatiramer acetate

S Haltmeier, M Yildiz, S Müller [...]

Multiple Sclerosis Journal

Search results